225 related articles for article (PubMed ID: 35186455)
1. Functional mechanism of hsa-miR-128-3p in epithelial-mesenchymal transition of pancreatic cancer cells via ZEB1 regulation.
Zheng T; Han W; Wang A; Wang Y
PeerJ; 2022; 10():e12802. PubMed ID: 35186455
[TBL] [Abstract][Full Text] [Related]
2. LncRNA ADPGK-AS1 promotes pancreatic cancer progression through activating ZEB1-mediated epithelial-mesenchymal transition.
Song S; Yu W; Lin S; Zhang M; Wang T; Guo S; Wang H
Cancer Biol Ther; 2018 Jul; 19(7):573-583. PubMed ID: 29667486
[TBL] [Abstract][Full Text] [Related]
3. Oridonin inhibition and miR‑200b‑3p/ZEB1 axis in human pancreatic cancer.
Gui Z; Luo F; Yang Y; Shen C; Li S; Xu J
Int J Oncol; 2017 Jan; 50(1):111-120. PubMed ID: 27878247
[TBL] [Abstract][Full Text] [Related]
4. Hsa-miR-497-3p impedes the proliferation and invasion of triple-negative breast cancer cells by controlling epithelial-mesenchymal transition through ZEB1 targeting.
Dong Q; Chen H; Li Y; Kong Y; Geng C; Liu Y
Cell Mol Biol (Noisy-le-grand); 2023 Aug; 69(8):78-83. PubMed ID: 37715420
[TBL] [Abstract][Full Text] [Related]
5. LncRNA XIST promotes pancreatic cancer migration, invasion and EMT by sponging miR-429 to modulate ZEB1 expression.
Shen J; Hong L; Yu D; Cao T; Zhou Z; He S
Int J Biochem Cell Biol; 2019 Aug; 113():17-26. PubMed ID: 31163263
[TBL] [Abstract][Full Text] [Related]
6. UBE2C, Directly Targeted by miR-548e-5p, Increases the Cellular Growth and Invasive Abilities of Cancer Cells Interacting with the EMT Marker Protein Zinc Finger E-box Binding Homeobox 1/2 in NSCLC.
Jin D; Guo J; Wu Y; Du J; Wang X; An J; Hu B; Kong L; Di W; Wang W
Theranostics; 2019; 9(7):2036-2055. PubMed ID: 31037155
[No Abstract] [Full Text] [Related]
7. miR-200a-3p regulates epithelial-mesenchymal transition and inflammation in chronic rhinosinusitis with nasal polyps by targeting ZEB1 via ERK/p38 pathway.
Wu Y; Sun K; Tu Y; Li P; Hao D; Yu P; Chen A; Wan Y; Shi L
Int Forum Allergy Rhinol; 2024 Jan; 14(1):41-56. PubMed ID: 37318032
[TBL] [Abstract][Full Text] [Related]
8. MiR-652 inhibits acidic microenvironment-induced epithelial-mesenchymal transition of pancreatic cancer cells by targeting ZEB1.
Deng S; Li X; Niu Y; Zhu S; Jin Y; Deng S; Chen J; Liu Y; He C; Yin T; Yang Z; Tao J; Xiong J; Wu H; Wang C; Zhao G
Oncotarget; 2015 Nov; 6(37):39661-75. PubMed ID: 26498682
[TBL] [Abstract][Full Text] [Related]
9. miR-1271 inhibits migration, invasion and epithelial-mesenchymal transition by targeting ZEB1 and TWIST1 in pancreatic cancer cells.
Liu H; Wang H; Liu X; Yu T
Biochem Biophys Res Commun; 2016 Apr; 472(2):346-52. PubMed ID: 26940738
[TBL] [Abstract][Full Text] [Related]
10. EZH2-Mediated microRNA-139-5p Regulates Epithelial-Mesenchymal Transition and Lymph Node Metastasis of Pancreatic Cancer.
Ma J; Zhang J; Weng YC; Wang JC
Mol Cells; 2018 Sep; 41(9):868-880. PubMed ID: 30304920
[TBL] [Abstract][Full Text] [Related]
11. miR-186 regulates epithelial-mesenchymal transformation to promote nasopharyngeal carcinoma metastasis by targeting ZEB1.
Tang L; Xiang Y; Zhou J; Li T; Jia T; Du G
Braz J Otorhinolaryngol; 2024; 90(1):101358. PubMed ID: 37989078
[TBL] [Abstract][Full Text] [Related]
12. Magnolol regulates miR-200c-3p to inhibit epithelial-mesenchymal transition and retinoblastoma progression by modulating the ZEB1/E-cadherin axis in vitro and in vivo.
Lai YH; Liu WL; Lee TY; Kuo CW; Liu YR; Huang CY; Chen YH; Chen IL; Wu SH; Wang SC; Lee PY; Liu CC; Lo J; Chang YC; Kuo HF; Hsieh CC; Li CY; Liu PL
Phytomedicine; 2023 Feb; 110():154597. PubMed ID: 36603340
[TBL] [Abstract][Full Text] [Related]
13. miR-144-3p inhibited the growth, metastasis and epithelial-mesenchymal transition of colorectal adenocarcinoma by targeting ZEB1/2.
Li T; Tang C; Huang Z; Yang L; Dai H; Tang B; Xiao B; Li J; Lei X
Aging (Albany NY); 2021 Jul; 13(13):17349-17369. PubMed ID: 34226299
[TBL] [Abstract][Full Text] [Related]
14. Tumor suppressor miR-128-3p inhibits metastasis and epithelial-mesenchymal transition by targeting ZEB1 in esophageal squamous-cell cancer.
Zhao L; Li R; Xu S; Li Y; Zhao P; Dong W; Liu Z; Zhao Q; Tan B
Acta Biochim Biophys Sin (Shanghai); 2018 Feb; 50(2):171-180. PubMed ID: 29329360
[TBL] [Abstract][Full Text] [Related]
15. miR302a-3p May Modulate Renal Epithelial-Mesenchymal Transition in Diabetic Kidney Disease by Targeting ZEB1.
Tang WB; Zheng L; Yan R; Yang J; Ning J; Peng L; Zhou Q; Chen L
Nephron; 2018; 138(3):231-242. PubMed ID: 29227974
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-574-3p regulates epithelial mesenchymal transition and cisplatin resistance via targeting ZEB1 in human gastric carcinoma cells.
Wang M; Zhang R; Zhang S; Xu R; Yang Q
Gene; 2019 Jun; 700():110-119. PubMed ID: 30917930
[TBL] [Abstract][Full Text] [Related]
17. The fibrotic microenvironment promotes the metastatic seeding of tumor cells into the lungs via mediating the ZEB1-AS1/miR-200b-3p/ZEB1 signaling.
Liu J; Cao L; Meng J; Li Y; Deng P; Pan P; Hu C; Yang H
Cell Cycle; 2020 Oct; 19(20):2701-2719. PubMed ID: 33017562
[TBL] [Abstract][Full Text] [Related]
18. miR-448 inhibits the epithelial-mesenchymal transition in breast cancer cells by directly targeting the E-cadherin repressor ZEB1/2.
Ma P; Ni K; Ke J; Zhang W; Feng Y; Mao Q
Exp Biol Med (Maywood); 2018 Mar; 243(5):473-480. PubMed ID: 29368542
[TBL] [Abstract][Full Text] [Related]
19. lncRNA TUG1-Mediated Mir-142-3p Downregulation Contributes to Metastasis and the Epithelial-to-Mesenchymal Transition of Hepatocellular Carcinoma by Targeting ZEB1.
He C; Liu Z; Jin L; Zhang F; Peng X; Xiao Y; Wang X; Lyu Q; Cai X
Cell Physiol Biochem; 2018; 48(5):1928-1941. PubMed ID: 30092578
[TBL] [Abstract][Full Text] [Related]
20. miR-590-3p suppresses cancer cell migration, invasion and epithelial-mesenchymal transition in glioblastoma multiforme by targeting ZEB1 and ZEB2.
Pang H; Zheng Y; Zhao Y; Xiu X; Wang J
Biochem Biophys Res Commun; 2015 Dec; 468(4):739-45. PubMed ID: 26556542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
